Neonc Technologies Holdings (NTHI) Amortizatization of Intangibles (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Amortizatization of Intangibles of $20406.0 for Q1 2026, up 11.46% quarter-over-quarter from $18308.0 in Q3 2025.
Neonc Technologies Holdings (NTHI) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Amortizatization of Intangibles for 3 consecutive years, with $20406.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortizatization of Intangibles changed N/A year-over-year to $20406.0; the TTM figure through Mar 2026 stood at $105790.0 (changed N/A YoY), while the FY2025 annual figure was $36461.0, down 85.18% from the prior year.
- Amortizatization of Intangibles climbed to $20406.0 in Q1 2026 per NTHI's latest filing, from $18308.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $67076.0 in Q3 2024 and bottomed at $18308.0 in Q3 2025.
- Historically, Amortizatization of Intangibles has averaged $43216.5 across 3 years, with a median of $43741.0 in 2024.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 72.71% in 2025 and fell as far as 72.71% in 2025.
- Neonc Technologies Holdings' Amortizatization of Intangibles stood at $67076.0 in 2024, then sank by 72.71% to $18308.0 in 2025, then gained by 11.46% to $20406.0 in 2026.
- Business Quant data shows NTHI's Amortizatization of Intangibles at $20406.0 in Q1 2026, $18308.0 in Q3 2025, and $67076.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | 18,590.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18,590.00 |
| Jun 30, 2026 | 18,590.00 |
| Mar 31, 2026 | 20,406.00 |
| Mar 31, 2026 | 20,406.00 |
| Sep 30, 2025 | 18,308.00 |
| Sep 30, 2025 | 18,308.00 |
| Dec 31, 2024 | 67,076.00 |
| Dec 31, 2024 | 67,076.00 |
| Sep 30, 2024 | 67,076.00 |
| Sep 30, 2024 | 67,076.00 |